Houston, TX, United States of America

Annemieke Kavelaars

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017-2021

Loading Chart...
3 patents (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested information about inventor Annemieke Kavelaars.

Title: Unveiling the Innovations of Inventor Annemieke Kavelaars

Introduction:

Annemieke Kavelaars is a talented inventor based in Houston, TX, US, recognized for his remarkable contributions to the field of medicine and pharmacology.

Latest Patents:

Kavelaars has obtained a total of 3 patents, with his most recent breakthrough being the development of Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy. These patents unveil innovative methods for treating this condition by administering selective inhibitors effectively.

Career Highlights:

With an illustrious career, Annemieke Kavelaars has made significant strides in the pharmaceutical industry. He has notably worked with esteemed organizations such as the University of Texas System and Regenacy Pharmaceuticals, LLC. These experiences have honed his skills and expertise in the development of groundbreaking medical solutions.

Collaborations:

Throughout his career, Kavelaars has collaborated with esteemed colleagues such as Cobi J Heijnen and Karen Krukowski. These collaborations have led to the successful implementation of novel ideas and the advancement of medical research.

Conclusion:

In conclusion, Annemieke Kavelaars stands as a pioneering inventor whose innovative work in pharmacology and medicine continues to make a profound impact. His dedication to developing cutting-edge solutions highlights his commitment to improving healthcare and enhancing the quality of life for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…